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Background: Pyrethroid resistance in the major malaria vector Anopheles funestus is rapidly expanding across
Southern Africa. It remains unknown whether this resistance has a unique origin with the same molecular basis or
is multifactorial. Knowledge of the origin, mechanisms and evolution of resistance are crucial to designing
successful resistance management strategies.
Results: Here, we established the resistance profile of a Zambian An. funestus population at the northern range of the
resistance front. Similar to other Southern African populations, Zambian An. funestus mosquitoes are resistant to
pyrethroids and carbamate, but in contrast to populations in Mozambique and Malawi, these insects are also DDT
resistant. Genome-wide microarray-based transcriptional profiling and qRT-PCR revealed that the cytochrome P450
gene CYP6M7 is responsible for extending pyrethroid resistance northwards. Indeed, CYP6M7 is more over-expressed in
Zambia [fold-change (FC) 37.7; 13.2 for qRT-PCR] than CYP6P9a (FC15.6; 8.9 for qRT-PCR) and CYP6P9b (FC11.9; 6.5 for
qRT-PCR), whereas CYP6P9a and CYP6P9b are more highly over-expressed in Malawi and Mozambique. Transgenic
expression of CYP6M7 in Drosophila melanogaster coupled with in vitro assays using recombinant enzymes and
assessments of kinetic properties demonstrated that CYP6M7 is as efficient as CYP6P9a and CYP6P9b in conferring
pyrethroid resistance. Polymorphism patterns demonstrate that these genes are under contrasting selection forces:
the exceptionally diverse CYP6M7 likely evolves neutrally, whereas CYP6P9a and CYP6P9b are directionally selected. The
higher variability of CYP6P9a and CYP6P9b observed in Zambia supports their lesser role in resistance in this country.
Conclusion: Pyrethroid resistance in Southern Africa probably has multiple origins under different evolutionary forces,
which may necessitate the design of different resistance management strategies.
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Malaria remains the most important vector-borne disease
in the world. Nearly 216 million cases are reported each
year, with an estimated 655,000 deaths in 2010, 86% of
which occurred in children under the age of five [1].
Malaria control relies extensively on the use of insecti-
cides, either in Long Lasting Insecticide Nets (LLINs) or
as Indoor Residual Sprays (IRS). Unfortunately, increasing
resistance to the available insecticide classes in the major
malaria vectors, such as Anopheles funestus, is threatening
the effectiveness of these control tools across Africa [2].
The recent WHO Global Plan for Insecticide Resistance
Management [2] highlights the growing threat posed by
insecticide resistance and calls for urgent action to imple-
ment suitable resistance management strategies against
malaria vectors to ensure the continued effectiveness of
control interventions. The elucidation of the molecular
basis of insecticide resistance in malaria vectors is a
crucial step in the design and implementation of these
resistance management strategies.
Resistance to pyrethroid insecticides is of particular
concern because these insecticides are the only class
recommended by WHO for the impregnation of LLINs.
Previous efforts to characterize the mechanisms of py-
rethroid resistance in An. funestus have revealed that
resistance is mainly driven by metabolic resistance with
cytochrome P450 genes playing a major role while target-
site resistance through knockdown resistance (kdr) was
absent [3-6]. Two duplicated cytochrome P450 genes,
CYP6P9a and CYP6P9b, were recently showed to play a
key role in the resistance observed in the Southern African
countries of Malawi and Mozambique [4]. The similarity
in the gene expression profiles and the presence of a
highly predominant resistance haplotype for each gene in
the two countries suggested that the resistance had a
unique origin [4]. However, recent susceptibility studies
have demonstrated that the pyrethroid resistance front
is expanding further northward across Southern Africa
[5,7,8]. The factors behind this expansion remained un-
characterized, and it remains unknown if, beyond Malawi
and Mozambique, the pyrethroid resistance front is still of
a unique origin as previously suggested [4].
Resistance can spread from a single origin through gene
flow between populations and can involve a single re-
sistance mechanism. This phenomenon was responsible
for the worldwide spread of DDT resistance under the
control of the CYP6G1 gene in the fruit fly [9]. The expan-
sion of the resistance front could also originate from mul-
tiple independent selection events by different selection
forces, potentially leading to the involvement of multiple
resistance mechanisms in the overall resistance front. This
phenomenon has been observed in the other major mala-
ria vector An. gambiae, in which pyrethroid/DDT resis-
tance is now widespread and is associated with variousmechanisms, including two 1014 F/S knockdown resist-
ance mutations [10,11] and over-transcription of various
metabolic genes [12-14]. It is not known if the expansion
of pyrethroid resistance in Southern African populations
of An. funestus is driven by different resistance me-
chanisms as in An. gambiae or by the same underlying re-
sistance mechanism under the control of different genes.
Furthermore, whether genes other than CYP6P9a and
CYP6P9b are also responsible for the expansion of the
resistance front remains to be determined. This informa-
tion has important operational implications for the imple-
mentation of resistance management strategies against
An. funestus across this region.
In addition, because the main tool used previously was a
microarray chip based on a set of 8,540 An. funestus
Expressed Sequenced Tags (ESTs) that did not cover the
full transcriptome of this species [15], it is possible that
other important resistance genes may contribute to the py-
rethroid resistance previously characterized in Mozambique
and Malawi. The availability of another RNAseq EST set
with more than 15,000 ESTs [16] has enabled increased
transcriptome coverage and a more comprehensive eluci-
dation of the molecular basis of pyrethroid resistance in
An. funestus.
The present study aimed to answer two main questions.
i) Is the pyrethroid resistance front across Southern African
An. funestus populations driven by same resistance mech-
anisms? ii) Are genes other than CYP6P9a and CYP6P9b
also responsible for the previously reported resistance to
pyrethroids in An. funestus in Mozambique and Malawi?
In this study, after establishing the resistance profile of a
Zambian An. funestus population, we used genome-wide
transcriptional and functional analyses to demonstrate that
the cytochrome P450 CYP6M7 has efficiently partnered
with the previously detected CYP6P9a and CYP6P9b to
expand the pyrethroid resistance front northward. Fur-
thermore, we demonstrate that these three genes are
under constrasting selection forces; the exceptionally poly-
morphic CYP6M7 evolving neutrally, whereas CYP6P9a
and CYP6P9b are both under directional selection.
Methods
Area of study and mosquito collection
Blood-fed female An. funestus adults resting indoors were
collected in houses between 06.00 and 12.00 AM in
Mbinga (Katete District) (14° 11' 0" S, 31° 52' 0" E) in
eastern Zambia in October 2010. The Malawian sample
was collected in the Chikwawa District (0° 45′ N, 34° 5′E)
in Southern Malawi in July 2009 and April 2010. The
Mozambican sample was collected in Tihuquine (Chokwe
District) (24° 33' 37" S, 33° 1' 20" E) in southern
Mozambique in January 2009 as recently described [4].
The collection method and rearing were conducted as
described previously [5,17]. F1 adults were generated from
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cages for subsequent experiments.
PCR species identification
All females used for individual oviposition were morpho-
logically identified as belonging to the An. funestus group
according to the key of [18]. A PCR assay was performed
using the protocol of [19] to confirm that all females that
laid eggs were An. funestus s.s.
Bioassays
Insecticide susceptibility assays were performed using
2- to 5-day-old F1 adults from pooled families from
Mbinga as described previously [5,17] following the
WHO protocol [20]. We tested the following insecticides:
0.75% permethrin (type I pyrethroid) and 0.05% delta-
methrin (type II pyrethroid); 0.1% bendiocarb (carbamate);
5% malathion (organophosphate); and the organochlorines
DDT (4%) and dieldrin (4%). The effect of the synergist
PBO was assessed in combination with 0.75% permethrin,
4% DDT and 0.1% bendiocarb. For each insecticide, 100
female mosquitoes were pre-exposed to 4% PBO impreg-
nated-paper for 1 h and immediately exposed to the in-
secticide paper for 1 h. Final mortality was assessed after
24 h and compared to the results obtained in the absence
of PBO.
Microarray
To detect the genes associated with the expansion of the
pyrethroid resistance front in An. funestus, a new 8×60 k
Agilent microarray chip was designed using the eArray
program (Agilent) (A-MEXP-2374) by adding the 15,527
Expressed Sequence Tags (ESTs) generated from another
transcriptome sequencing of An. funestus [16] to the
previous 4×44 k array used by [4]. Each array contained
60mer probes designed from 8,540 ESTs generated from
An. funestus transcriptome 454 sequencing [15] (2 probes
for each EST), a set of 2850 An. funestus cDNAs from
GenBank (2 probes for each EST), a set of P450 genes
from the rp1 and rp2 QTL BAC sequence [21,22]
(3 probes for each gene), and the 13,000 transcripts of the
complete An. gambiae genome. In addition, all of the An.
gambiae detoxification genes previously present on the
An. gambiae detox chip [23] were added to this chip with
3 probes for each gene to exploit possible gene sequence
conservation between An. gambiae and An. funestus.
RNA was extracted from three batches of ten 2- to
5-day-old An. funestus females alive after exposure to
0.75% permethrin (Resistant, R) and unexposed mosqui-
toes of the fully susceptible laboratory strain FANG
(Susceptible, S) using the Picopure RNA Isolation Kit
(Arcturus). The quantity and quality of the extracted
RNA were assessed using a NanoDrop ND1000 spectro-
photometer (Thermo Fisher) and Bioanalyzer (Agilent,Santa Clara, CA, USA), respectively. Complementary
RNA (cRNA) was amplified from each sample using the
Agilent Quick Amp Labeling Kit (two-color) following
the manufacturer’s protocol. cRNAs from the resistant
samples (R) were labeled with cy5 dye, and cRNAs from
the susceptible strain FANG (S) were labeled with the
cy3 dye. cRNA quantity and quality were assessed before
labeling using the NanoDrop and Bioanalyzer. Labeled
cRNAs were hybridized to the arrays for 17 h at 65°C
according to the manufacturer’s protocol. Five hybridiza-
tions were performed for each location by swapping the
biological replicates.
Microarray data were analyzed using Genespring GX
12.0 software. To identify differentially expressed genes,
a cut-off of 2-fold-change (FC) and a statistical signifi-
cance of P < 0.01 with Benjamini-Hochberg correction
for multiple testing and q < 0.01 with Storey with boot-
strapping were applied. The predicted functions of all
the transcripts and ESTs used for this microarray chip
were identified by the BLAST2GO program [24,25].
Quantitative reverse transcriptase PCR
The expression patterns of some of the genes most associ-
ated with resistance based on the microarray analyses
were assessed by qRT-PCR using the primers listed in
Additional file 1: Table S1. In the case of the new candi-
date resistance gene CYP6M7, fold change was obtained
from three independent primer pairs to further validate
the microarray over-expression. One microgram of total
RNA from each of the three biological replicates from the
Resistant (R), Control (C) (mosquitoes from each location
not exposed to insecticide) and FANG (S) populations for
the three countries was used as the template for cDNA
synthesis using Superscript III (Invitrogen) with oligo-
dT20 and RNase H according to the manufacturer’s
instructions. A serial dilution of cDNA was used to estab-
lish standard curves for each gene to assess PCR efficiency
and quantitative differences between samples. qRT-PCR
amplification was performed as described previously
[4,26]. The relative expression level and FC of each target
gene in R and C relative to S were calculated according to
the 2-ΔΔCT method incorporating the PCR efficiency [27]
after normalization with the housekeeping genes ribo-
somal protein S7 (RSP7; AGAP010592) and actin 5C
(AGAP000651).
Tissue-specific expression of candidate resistance genes
To identify the tissues where the main resistance genes
are expressed, we performed a qRT-PCR assay for these
genes in sets of cDNA synthesized from RNA extracted
from the heads, thoraces and abdomens of female mos-
quitoes from Zambia that were not exposed to insecti-
cides. A total of 30 females were dissected, and three
sets of 10 heads, 10 abdomens and 10 thoraces were
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described above, with the expression level of each gene
in each body part determined in relation to the FC in
the whole mosquito.
Transgenic expression of candidate genes in Drosophila
strains
To establish whether over-expression of the candidate
gene CYP6M7 alone can confer resistance to different
pyrethroids, transgenic Drosophila melanogaster flies ex-
pressing this gene were generated using the GAL4/UAS
system. The construction of the transgenic strain fol-
lowed the protocol recently successfully used for the
P450s CYP6P9a and CYP6P9b [4].
Briefly, full-length CYP6M7 was amplified from cDNA
using the Phusion High-Fidelity DNA Polymerase (Thermo
Scientific) and cloned into the pJET1.2/blunt cloning
vector (Thermo Scientific). The primers used are listed in
Additional file 1: Table S1. After sequence analysis, one
clone that was predominant in the three countries was
selected to construct transgenic flies and cloned into the
pUASattB vector using primers containing restriction sites
for EcoRI and XbaI. Using the PhiC31 system, clones were
transformed into the germ line of a D. melanogaster strain
carrying the attP40 docking site on chromosome 2
[“y1w67c23; P attP40”, “1;2”] by Genetic Services (MA,
USA) to generate the transgenic line UAS-CYP6M7.
Ubiquitous expression of the transgene CYP6M7 in adult
F1 progeny (experimental group) was obtained after cros-
sing virgin females from the driver strain Act5C-GAL4
["y [1] w[*]; P(Act5C-GAL4-w)E1/CyO","1;2"] (Bloomington
Stock Center, IN, USA) with homozygote UAS-CYP6M7
males. Similarly, adult F1 control progeny (control group)
with the same genetic background as the experimental
group but without expression of CYP6M7 were obtained
by crossing virgin females from the driver strain Act5C-
GAL4 and UAS recipient line males (which do not carry
the pUASattb-CYP6M7 insertion).
Insecticide contact bioassays: Experimental and con-
trol F1 Drosophila melanogaster females were selected for
use in insecticide bioassays. A comparison of the mortality
rates of the experimental group and control group was
used to assess whether CYP6M7 could confer resistance.
Post-eclosion females that were 2 to 5 days old were used
in a contact assay with the pyrethroids deltamethrin and
permethrin. After assessing a range of doses to identify
the best discriminating dose for flies, 2% permethrin- and
0.15% deltamethrin-impregnated filter papers were pre-
pared in acetone and Dow Corning 556 Silicone Fluid
(BHD/Merck, Germany) for bioassays. These discrimi-
nating doses differ from that of mosquitoes due to various
differences between both species notably in size and cu-
ticle thickness. These papers were rolled and introduced
into 45 cc plastic vials to cover the entire wall. The vialswere plugged with cotton soaked in 5% sucrose. Then,
20–25 flies were placed in each vial, and the mortality plus
knockdown was scored after 1 h, 2 h, 3 h, 6 h, 12 h and
24 h of exposure to the insecticide. For all assays, at least
6 replicates were performed. Student’s t-test was used to
compare the mortality plus knockdown of the experi-
mental group with the control group.
Confirmation of transgene expression in transgenic
flies by qRT-PCR: To confirm the expression of CYP6M7
in the experimental group and the absence of expression
in the control groups, total RNA was extracted from three
pools of 5 flies. cDNA was synthesized as described above.
The relative expression levels of the transgene were
assessed by qRT-PCR in the experimental F1 progeny as
well as in the respective controls with normalization with
the RPL11 housekeeping gene.
Heterologous expression of candidate genes in E. coli
Cloning of CYP6M7, CYP6P9a and CYP6P9b for ex-
pression in E. coli: The CYP6M7, CYP6P9a and CYP6P9b
genes were fused to a bacterial ompA+ 2 leader sequence
and expressed in E. coli JM109 cells using the pCW-ori +
vector as previously described [28-30]. Briefly, a DNA frag-
ment containing the coding sequence for the ompA signal
peptide with a downstream alanine-proline linker and ap-
proximately the first 20 nucleotides of each gene was first
amplified using KAPA HiFi PCR (Kappa Biosystems) and
50 ng of E. coli JM109 DNA as the template using the spe-
cific primers (OMPA+ 2_F and the reverse primers:
OMPA+ 2-CYP6M7, OMPA+ 2-CYP6P9a and OMPA+
2-CYP6P9b, Additional file 1: Table S1). The KAPA HiFi
PCR conditions were: 1 cycle at 95°C for 5 min; 35 cycles
of 94°C for 20 s, 57°C for 30 s and elongation at 72°C for
90 s; and 1 cycle at 72°C for 5 min.
Next, the same CYP6M7 clone used for the Drosophila
transgenic study, the CYP6P9a and CYP6P9b clones used
previously [4], and the ompA+ 2 PCR fragment were used
as templates in a fusion PCR under the same conditions
described above. The full-length sequence of each gene in-
corporating the ompA+ 2 leader was ligated into a modi-
fied pCW-ori + vector plasmid, pB13 [29], via EcoRI and
XBaI sites to produce pB13::ompA+ 2-CYP6PM7, pB13::
ompA+ 2-CYP6P9a and pB13::ompA+ 2-CYP6P9b. These
constructs were sequenced to confirm the absence of PCR
errors.
Membrane preparation: For all genes, E. coli JM109
cells were co-transformed with pB13::ompA+ 2-CYP6M7,
pB13::ompA + 2-CYP6P9a or pB13::ompA+ 2-CYP6P9b
and a plasmid containing the An. gambiae cytochrome
P450 reductase, pACYC-AgCPR [28]. The expression of
each gene, membrane isolation and P450 content were de-
termined as previously described [28,30]. The membranes
were stored in aliquots at −80°C and assayed for total pro-
tein concentration using NanoDrop spectrophotometer,
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cytochrome c reduction [32]. The histidine-tagged An.
gambiae cytochrome b5 (Cyt-b5) was generated as pre-
viously described by Stevenson et al. [30] and used for the
metabolism assays.
Metabolism assays: Pyrethroids were dissolved in
methanol (HPLC grade, Fisher Scientific) immediately
before use at a final working concentration of 0.02 mM. As
previously described by Stevenson et al. [30], the reactions
consisted of the following: 45 pmoles of P450, 0.2 M Tris
HCl pH 7.4, 0.25 mM MgCl2, 1 mM glucose-6-phosphate,
0.1 mM NADP+ (Melford), 1 unit/ml glucose-6-phosphate
dehydrogenase (G6PDH), 0.8 μM Cyt-b5 and 0.2 mM pyr-
ethroid insecticides in a final volume of 200 ml. NADP +
was excluded from the minus NADPH control. Mem-
branes expressing P450 and CPR with Cyt-b5 were applied
to the side of a 1.5 ml Eppendorf tube, and buffer was
added to the bottom of the tube. After a 5 min pre-
incubation, the reactions were initiated by vortexing and
incubated at 30°C with shaking at 1000 rpm.
HPLC analysis: Reactions were stopped with 0.1 ml of
cold methanol and incubated with shaking (1000 rpm) for
5 min at 30°C to dissolve all available pyrethroids. The
samples were then centrifuged at 16,000 rpm for 10 min
at 4°C, and 150 μl of the supernatant was transferred into
HPLC vials. The quantity of pyrethroid remaining in the
samples was determined by reverse-phase HPLC with a
monitoring absorbance wavelength of 226 nm (Agilent
1260 Infinity). A 100 μl sample was loaded into an iso-
cratic mobile phase of 90% methanol and 10% water with
a flow-rate of 1 ml/min, and substrate peaks were sepa-
rated on a 250 mm C18 column (Acclaim™ 120, Dionex)
at 23°C.
Turnover and kinetic assays: To determine the turn-
over of P450s with pyrethroids, experiments with delta-
methrin and permethrin were performed in which the
incubation time was varied from 0 to 30 minutes. The
turnover was calculated from the plot of the initial vel-
ocity vs. time at zero-order phase by fitting the data to a
non-linear regression using the enzyme kinetic module
of GraphPad Prism 6.03 (GraphPad Software Inc., La
Jolla, CA, USA). Steady-state kinetic parameters were
obtained by measuring the rate of reaction under linear
conditions for 10 minutes while varying the substrate
concentration from 0 to 20 μM. KM and Vmax were
established from the plot of substrate concentrations
against the initial velocities and fitting of the data to the
Michaelis-Menten equation using GraphPad Prism.
Catalytic constants and efficiencies were determined
from the steady-state parameters.
Genetic variability of candidate genes
The full-length coding regions of CYP6M7 were ampli-
fied from cDNA of permethrin-resistant samples fromMalawi, Mozambique and Zambia and from the suscep-
tible FANG strain to assess the role of allelic variation in
resistance. The amplification was performed using the
same cDNA synthesized for qRT-PCR with the Phusion
polymerase, which was cloned and sequenced as de-
scribed above.
In addition, to assess the potential association between
allelic variation and pyrethroid resistance, a genomic frag-
ment spanning the full-length CYP6M7 gene and a portion
of the 5’UTR region were amplified and directly sequenced
in five susceptible (dead after a 1 h exposure) and five
resistant (alive after a 1 h exposure to 0.75% permethrin)
mosquitoes from Zambia, Malawi and Mozambique. The
primers used are listed in Additional file 1: Table S1. Simi-
larly, both CYP6P9a and CYP6P9b were also amplified
and sequenced from the Zambia samples for comparison
with the polymorphism profiles previously obtained in
Malawi and Mozambique samples [4]. Polymorphic posi-
tions were detected through manual analysis of sequence
traces using BioEdit and as sequence differences in mul-
tiple alignments using ClustalW [33]. DnaSP 5.1 [34] was
used to define the haplotype phase (through the Phase
program) and to assess genetic parameters of each gene
such as nucleotide diversity π and haplotype diversity. A
maximum likelihood phylogenetic tree of the haplotypes
for each gene was constructed using MEGA 5.2 [35], and a
haplotype network was built using the TCS program [36]
(95% connection limit; gaps treated as a fifth state) to
assess the potential connection between haplotypes and
resistance phenotypes.
Test of selection on CYP6M7: To assess the possibility
of selection acting on CYP6M7 in all three countries and
its role in pyrethroid resistance, the departure from neu-
trality was tested using the codon-based Z test of selec-
tion. As implemented in MEGA5.2, this test uses the Nei
and Gojobori method to compute the numbers of syno-
nymous (dS) and non-synonymous (dN) substitutions per
site and the numbers of potentially synonymous and
potentially non-synonymous sites [37]. The dN/dS ratio
was calculated, and the probability of rejecting the null
hypothesis of strict neutrality (H0: dN = dS) in favor of the
alternative purifying (H1: dN < dS) or positive selection
hypotheses (H1: dN > dS) was estimated using the boot-
strap method (1000 replicates) in MEGA5.2.
Results
Susceptibility status of An. funestus in Zambia
The bioassays performed on the An. funestus population
from Mbinga (Katete district) in Zambia indicated that this
population is highly resistant to both type I (permethrin)
and type II (deltamethrin) pyrethroids, with mortality rates
of 15.7 and 5%, respectively, for females (Figure 1). This
resistance level is higher than that previously reported
in Malawi (47.2 and 42.3% mortality, respectively, for
Figure 1 Susceptibility profile of the An. funestus population from the Katete district in Zambia to the main insecticides and when
exposed to the synergist piperonyl butoxide (PBO). The data are presented as the mean of at least four replicates and error bars represent
standard deviation.
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Mozambique (no mortality after a 2 h exposure for both
pyrethroid types) [17].
This Zambian population is also highly resistant to
carbamates, with no mortality in females and only 5%
mortality in males after a 1 h exposure to 0.1% bendiocarb.
This level of carbamate resistance is much higher than that
previously reported in Mozambican (70% mortality) [17]
and Malawian (60% mortality) [5,8] populations. Surpri-
singly, DDT resistance was also detected in the Zambian
An. funestus population, with 60.6% mortality in females.
This profile is significantly different from that in other
Southern African populations; full susceptibility to DDT
was observed in the Mozambican population, and only
moderate resistance was observed in the Malawian popu-
lation (93% mortality). Thus, despite their similar pyre-
throid resistance profiles, the Zambian population differs
from the Malawian and Mozambican populations. How-
ever, full susceptibility to malathion (organophosphate)
and dieldrin was observed, with 100% mortality similar
to that observed in the Mozambican and Malawian
populations.
A near full susceptibility to permethrin was restored in
the Zambian population after exposure to the synergist
piperonyl butoxide (PBO), with 100% mortality in females.
This result suggests that, as observed previously in
Malawi and Mozambique, cytochrome P450 genes play
a major role in the pyrethroid resistance observed in
Zambia. Similarly, after PBO exposure, significant recov-
ery of susceptibility to the carbamate bendiocarb from
0% to 86.5% was observed, further supporting an im-
portant role of P450s in the carbamate resistance ob-
served in Zambia. However, the absence of a completerecovery of susceptibility suggests the potential involve-
ment of other mechanisms. Exposure to PBO only mo-
derately increased DDT mortality from 60.6 to 83.8%,
suggesting that the potential role of P450s in DDT
resistance might not be as important as in pyrethroid or
carbamate resistance.
Genome-wide microarray-based transcriptional profiling
A new genome-wide An. funestus custom Agilent micro-
array chip containing 60,000 probes (60mer) was used to
identify genes associated with pyrethroid resistance in a
Zambian population for the first time. The same chip was
also used to detect novel resistance genes in Malawian and
Mozambican populations that might have been missed by
the previously less comprehensive chip [4]. Labeled com-
plementary RNA (cRNA) was successfully obtained from 3
biological replicates of resistant (R) (mosquitoes alive after
a 1 h exposure to 0.75% permethrin) from each country
and susceptible (S) (unexposed mosquitoes from the
fully susceptible laboratory strain FANG) populations.
The number of probes that were differentially expressed
(>2-fold change, FC) between R and S mosquitoes for
each country and between them is indicated in Figure 2A
(P < 0.01) and Additional file 2: Figure S1A (P < 0.05).
Overall, 639 probes were differentially expressed in the
Mozambican population (298 over-expressed and 341
under-expressed), 3038 in the Malawian population (1327
over-expressed and 1711 under-expressed) and 2196 in
the Zambian population (748 over-expressed and 1448
under-expressed). A total of 120 probes were differentially
expressed in all three countries.
Genes commonly up-regulated in all three countries:
An analysis of the list of probes commonly up-regulated
Figure 2 Transcriptional profiling of resistant populations. A) Summary of probes differentially regulated in each of the 3 countries. The
Venn diagrams show the number of probes significantly (P < 0.01) up- or down-regulated (FC > 2) in each country as well as the commonly
expressed probes. Upward arrows indicate up-regulated probes, and downward arrows represent down-regulated probes. B) Relative expression
of the three main detoxification genes (CYP6P9a, CYP6P9b and CYP6M7) by microarray between the three countries (based on probes with
highest expression); C) Differential expression of 15 genes up-regulated between permethrin-resistant (R) and -susceptible FANG (S) mosquitoes
in the Mozambican (MZ), Malawian (ML) and Zambian field populations (ZB). Fold-change for CYP6M7 was obtained from the average of three
independent primer pairs. Error bars represent standard deviation (N = 3). The presence of * on top of the three fold changes for each gene
indicates a statistically significant over-expression in all locations compared to the FANG susceptible strain. “ns” is added when the difference was
not significant. D) Tissue-specific expression of CYP6P9a, CYP6P9b and CYP6M7 in field permethrin-resistant female An. funestus mosquitoes.
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two duplicated P450 genes CYP6P9a and CYP6P9b were
among the most up-regulated genes for Mozambican and
Malawian mosquitoes, with FCs of 75.5 and 39.4, respec-
tively, for CYP6P9a and 88.2 and 24, respectively, for
CYP6P9b (Additional file 1: Table S2). However, although
these two genes were also significantly up-regulated in the
Zambian sample, the FC was much lower than for the
Mozambican and Malawian samples, with FCs of only
15.6 and 11.9, respectively, for CYP6P9a and CYP6P9b.
This two to seven-fold decrease in the expression level of
both genes from south Mozambique to Malawi and to
Zambia was observed across the three distinct microarray
probes used for each gene (Figure 2B). Such change in
expression level suggests a variation in the roles these
duplicated P450 genes play in the pyrethroid resistance
observed across Southern Africa.This hypothesis was further supported by the observa-
tion that the most highly over-expressed detoxification
gene in the Zambian sample was another CYP6 family
P450 gene, CYP6M7, which displayed an FC of 37.7,
corresponding to a 2- to 3-fold greater up-regulation com-
pared to CYP6P9a and CYP6P9b. This gene is located in
the genomic region spanning the pyrethroid resistance
rp2 QTL on chromosome 2 L detected in the FUMOZ-R
pyrethroid-resistant laboratory strain [21]. CYP6M7 is
the ortholog of the CYP6M3 gene in An. gambiae
(AGAP008213), which is over-expressed in resistant mos-
quitoes but with a much lower FC than that described in
this study [26,38]. CYP6M7 was also up-regulated in the
Mozambican and Malawian samples but with a lower FC
than in the Zambia sample (25.7 and 12.5, respectively).
This result suggests that CYP6M7 might play a more
important role in the pyrethroid resistance observed in
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genes.
Another novel gene identified using the 8x60k chip
was the P450 CYP6AA1, which was also commonly up-
regulated in the samples from all three countries, with
two-fold over-expression in the Mozambican sample
(FC = 13.2) than in the Malawian (FC = 5.2) and Zambian
(FC = 5.3) samples. This gene is the ortholog of CYP6AA3
in An. minimus, which was recently shown to metabolize
pyrethroids [39] and is located on the 2R chromosome in
the rp1 QTL in the same P450 cluster with CYP6P9a and
CYP6P9b [22]. Other newly identified detoxification genes
that were up-regulated in the samples from all three coun-
tries include three other P450s, CYP6Y2 (located in rp2
QTL), CYP304B1 and CYP9K1, although these genes were
expressed at lower levels (FC < 4, see Additional file 1:
Table S2).
Two other P450 genes, CYP9J11 (located around the
rp3 QTL) and CYP6P2 (located around rp1), were also
up-regulated in the three populations (Additional file 1:
Table S2). Other genes commonly up-regulated in the
three countries are listed in Additional file 1: Table S2.
Probes commonly down-regulated in all three coun-
tries: The most down-regulated genes in the samples from
all three countries were previously reported to be down-
regulated in Mozambican and Malawian samples [4] and
include a cationic amino acid transporter, a monkey king
protein gene, an isoform c gene and several probes for cyto-
chrome c oxidase subunit 3 (Additional file 1: Table S3).
Transcriptional profiling of the Zambian population
The transcriptional profile of the Zambian population was
analyzed further because it had not been previously
performed with the previous 4×44 k chip. This analysis
revealed that, in addition to the main genes CYP6P9a,
CYP6P9b and CYP6M7, other detoxification genes were
up-regulated. The majority of these genes encode cyto-
chrome P450s; nineteen P450 genes were up-regulated
(P < 0.01) (Table 1). These P450s include CYP6M4
(FC = 5.1) which was also up-regulated in the Malawian
sample (FC = 4.3) (Table 1) but not the Mozambican
sample (Table 1), CYP315A1 (FC = 4.5) and CYP6N1
(FC = 2.9).
Two carboxylesterases were also up-regulated in
Zambia. The COEAE1A gene (FC = 12), an ortholog of
AGAP001722 in An. gambiae and COE09916, an ortholog
of AGAP010917 in An. gambiae (FC = 2.2). COEAE1A
was also over-expressed in the Malawian sample (FC = 6.1)
but not the Mozambican sample, whereas COE09916 was
only over-expressed in the Zambian sample.
Another important detoxification gene family that was
up-regulated in the Zambian sample is the glutathione
S-transferases, with 4 genes notably over-expressed
(Table 1). GSTD3 was the most highly over-expressedmember of this family (FC = 7.8) whereas the three other
GSTs were up-regulated at a lower level (FC < 3); GSTD1-5,
GSTe2 and GSTe1. GSTD3 is not over-expressed in the
DDT-susceptible populations of Mozambique and Malawi.
Other up-regulated gene families include aldehyde oxi-
dases, ABC transporters, proteases (such as trypsin and
chymotrypsin 1), cuticle proteins, UDP glucosyl trans-
ferases, heat shock proteins (HSP70) argininosuccinate
lyase and short chain dehydrogenases (Table 1).
Validation of the microarray results by qRT-PCR
Quantitative real-time PCR (qRT-PCR) was used to
validate the microarray results for fifteen of the most
up-regulated detoxification genes in the samples from
the three countries, including 11 P450 genes, one gluta-
thione S-transferase gene (GSTe2), the argininosuccinate
lyase gene, one aldehyde oxidase gene and one gene with
unknown function (Combined_c3440). The qRT-PCR
results confirmed the over-expression patterns observed
by microarray, although with generally lower fold change
values (Figure 2B). A similar expression pattern was ob-
served for the control samples that were not exposed to
insecticides from each of the three countries (Additional
file 2: Figure S1B). Particular attention was paid to the
CYP6M7 to validate its high over-expression. The qRT-
PCR results from the three independent primer pairs on
CYP6M7 confirmed that this gene is over-expressed in
the three countries with FC of 21.0, 11.75 and 13.25 re-
spectively in Mozambique, Malawi and Zambia when aver-
aging over the three primers. In Zambia, the CYP6M7 was
most over-expressed (FC 13.25) than CYP6P9a (FC 8.9)
and CYP6P9b (FC 6.53) although the difference is signifi-
cant only against CYP6P9b. The Mozambique sample
exhibited the highest over-expression for the three main
pyrethroid candidate resistance gene in correlation with
microarray in line with the high pyrethroid resistance
observed in this population [17]. However, in Malawi, no
significant difference was observed in the expression of the
three genes in contrast to microarray. A notable higher
over-expression was observed for the CYP6Z1 P450
gene than with microarray for all the three countries (13 <
FC < 18.9 for qRT-PCR while FC < 3 for microarray). A
significant correlation between the qRT-PCR and micro-
array results was observed in the combined sample of
the three countries (R2 = 0.4;P<0.05) (Additional file 2:
Figure S1C).
Tissue-specific expression profile of main candidate
resistance genes: Assessment of the tissue-specific ex-
pression profile of the main resistance genes by qRT-PCR
showed that CYP6P9a, CYP6P9b and CYP6M7 were all
similarly expressed in the head, thorax and abdomen
(Figure 2C). Indeed, the fold-change observed in these
body parts is not significantly different from that of the
whole body. This result suggests that expression of these
Table 1 The most up-regulated detoxification genes in Zambia (ZB), Malawi (ML) and Mozambique (MZ) (P < 0.01)
Systematic name Orthologs in An. gambiae Fold change (FC) Description
ZB ML MZ
Afun007663 (CYP6M7) AGAP008213-PA 37.7 12.5 25.7 Cytochrome p450
CYP6P9a AGAP002865-PA 15.6 39.4 75.5 Cytochrome p450
CYP6P9b AGAP002865-PA 11.9 24.0 88.2 Cytochrome p450
Afun008614 (CYP6AA1) AGAP002862-PA 5.3 5.2 13.2 Cytochrome p450
Afun007346 AGAP007990-PA 2.7 3.1 3.5 Glucosyl glucuronosyl transferases
Afun007469 (CYP9J11) AGAP012296-PA 4.1 4.8 4.0 Cytochrome p450
CYP6Y2 3.9 2.9 4.4 Cytochrome p450
Afun012197 (CYP6Z1) AGAP003066-PA 2.8 2.9 3.9 Cytochrome p450
Afun009335 (CYP6AG1) AGAP003343-PA 2.4 2.7 2.6 Cytochrome p450
Afun012194 (CYP6P2) AGAP002869-PA 2.6 2.7 3.9 Cytochrome p450
Afun007769 (CYP9K1) AGAP000818-PA 3.6 2.4 2.3 Cytochrome p450
Afun000493 AGAP006225-PA 3.0 2.2 2.6 Aldehyde oxidase
Afun010360 AGAP006222-PA 2.8 2.0 2.1 Glucosyl glucuronosyl transferases
combined_c920 (GSTe2) 2.5 3.4 2.8 Glutathione-s-transferase gst
Afun009227 AGAP008141-PA 25.4 66.3 Argininosuccinate lyase
Afun010614 AGAP006380-PA 4.0 2.5 atp-binding cassette sub-family a member
Afun007482 AGAP002693-PA 3.9 2.3 atp-binding cassette sub-family f member 2
Afun011877 AGAP013384-PA 2.5 2.1 atp-binding cassette transporter
Afun002473 AGAP000553-PA 6.6 4.5 atp-binding-cassette protein
Afun009492 AGAP001722-PA 12.0 5.9 Carboxylesterase
CD577459.1 2.3 3.0 Cuticle protein
CYP6M4 5.1 5.3 Cytochrome p450
Afun009522 AGAP012292-PA 2.4 4.5 Cytochrome p450
Afun003394 (CYP315A1) AGAP000284-PA 4.5 2.4 Cytochrome p450
Afun007127 (CYP4C36) AGAP009241-PA 2.1 2.4 Cytochrome p450
Afun007499 (GSTd1-5) AGAP004164-PA 2.8 2.9 Glutathione transferase
combined_c4173 4.6 4.8 Glycoprotein 93
combined_c557 7.6 11.8 Trypsin
CD578169.1 3.0 6.0 Trypsin
Afun007646 AGAP006225-PA 2.0 3.4 Aldehyde oxidase
Afun008347 AGAP009828-PA 4.2 2.2 Chymotrypsin 1
Afun013935 AGAP010917-PA 2.2 Carboxylesterase
Afun013921 AGAP006709-PA 31.3 Chymotrypsin 1
Afun004392 AGAP008213-PA 2.3 Cytochrome p450
Afun008909 AGAP002416-PA 2.1 Cytochrome p450
Afun012666 AGAP002429-PA 2.1 Cytochrome p450
Afun008354 (GSTD3) AGAP004382-PA 7.8 Glutathione transferase
Afun013481(GSTe1) AGAP009195-PA 2.3 Glutathione-s-transferase gst
Afun011899 AGAP012514-PA 2.0 Short-chain dehydrogenase
combined_c4812 2.7 Short-chain dehydrogenase
AGAP007662-RA AGAP007662-RA 2.4 Short-chain dehydrogenase
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tissues involved in detoxification, such as the midgut,
Malpighian tubules, or fat body [40].
Transgenic expression of CYP6M7 in Drosophila flies
To confirm that the over-transcription of CYP6M7 alone
can confer pyrethroid resistance, transgenic D. melanoga-
ster individuals expressing a CYP6M7 allele (derived from
permethrin resistant field mosquitoes) under the control
of the ubiquitous Act5C-GAL4 driver were successfully
generated. qRT-PCR analysis confirmed that CYP6M7 was
expressed only in transgenic Act5C-CYP6M7 F1 progeny
(2-ΔΔCT of 0.17); virtually no expression was observed in
the control (same genetic background but without
CYP6M7 gene) (2-ΔΔCT of 4.8 × 10−5) (Additional file 2:
Figure S1D). Contact bioassays performed with 2% per-
methrin (type I pyrethroid) and 0.15% deltamethrin (type
II) revealed that flies over-expressing CYP6M7 were resis-
tant to both pyrethroid types, resulting in a significantly
reduced mortality/knockdown rate for both insecticides
compared to that observed for control flies. For permeth-
rin, significantly reduced mortality/knockdown rates were
recorded at five different exposure times of transgenicFigure 3 Functional confirmation of the role of CYP6M7 in pyrethroid
of a bioassay with 2% permethrin (A) and 0.15% deltamethrin (B) against t
from the cross between the UAS-CYP6M7 females and w1118 males (which
are the mean ± SEM (n = 6). (C) The proportion of 10 μM insecticide cleare
indicated by bar height. Error bars represent standard deviation (N = 3).Act5C-CYP6M7 individuals when compared with the
control group not expressing CYP6M7. These exposure
times were 2 h (3.15 vs. 35.04%, P = 0.027), 3 h (3.15 vs.
44.92%, P = 0.0066), 6 h (13.20 vs. 52.39%, P = 0.0039),
12 h (11 vs. 50.96%, P = 0.0023) and 24 h (26.57 vs.
55.59%, P = 0.038) (Figure 3A). Similarly, a significant
reduction in mortality/knockdown rates was also recorded
for deltamethrin in the transgenic Act5C-CYP6M7 flies
compared to the control group after 3 h (13.52 vs. 37.5%,
P = 0.037), 6 h (22.10 vs. 54.71%, P = 0.041) and 12 h (18.1
vs. 51.30%, P = 0.032) (Figure 3B). These results demon-
strate that CYP6M7 over-transcription alone is sufficient
to confer resistance to both type I and type II pyrethroids.
Heterologous expression of CYP6M7, CYP6P9a and
CYP6P9b in Escherichia coli
Recombinant CYP6M7 protein was successfully expressed
at 21°C and 150 rpm and harvested 48 h after induction
with δ-ALA and IPTG. The co-expression of the CYP6M7
enzyme in E. coli produced CO-difference spectrum typi-
cal of a good-quality functional enzyme expressed pre-
dominantly as P450 with low P420 content. Previous
attempts to express the recombinant enzyme from theresistance. A) Transgenic expression of CYP6M7 in Drosophila. Results
he transgenic Act5C-CYP6M7 strain (Experimental) and the progeny
do not over-express the P450 transgene) (Control). The data shown
d by 0.1 μM P450 with 0.8 μM cyt b5 in the presence of NADPH is
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mation with cytochrome P450 reductase (CPR) into E. coli
JM109 cells had been unsuccessful [4]. Here, successful
expression was achieved by allowing the starter culture to
grow until the optical density at 595 nm reached 0.7-0.8
and by increasing the final concentrations of IPTG and
δ-ALA used for induction from 1 M and 0.5 M, respec-
tively, to 1.25 M and 0.75 M. The expression temperature
was 24°C for the first 24 h after induction and was then
lowered to 18°C at 24–48 h. Optimal expression of
CYP6P9a was obtained 36–48 h post-induction, as indi-
cated by a good-quality CO-difference spectrum. Details of
the expression of CYP6P9b were previously reported [4].
Metabolism assays with CYP6M7: To confirm that
CYP6M7 can metabolize pyrethroid insecticides, the
recombinant enzyme produced from this gene was
assessed in in vitro metabolism assays. The metabolism
assays demonstrated that recombinant CYP6M7 meta-
bolized both type I and type II pyrethroid insecticides
(Figure 3C). Indeed, for the type I pyrethroids, significant
substrate depletion rates of 68.28% ± 0.16 (P < 0.001) and
62.19% ± 0.6 (P < 0.001) were observed for permethrin and
bifenthrin (as determined by the disappearance of sub-
strate (20 μM) after 90 min), respectively, compared to theFigure 4 Turnover and kinetic profiles of CYP6P9a, CYP6P9b and CYP6
of the three enzymes with deltamethrin (A) and permethrin (B) is shown; (
deltamethrin, and (D) is the plot with permethrin. The data are presented acontrols (with no NADPH). CYP6M7 could also deplete
the same concentration of the type II pyrethroids delta-
methrin and lambda-cyhalothrin at rates of 53.60% ± 3.5
(P < 0.001) and 48.24% ± 1.97 (P < 0.001), respectively
(Figure 4A). Similarly, CYP6M7 can also metabolize the
ether pyrethroid etofenprox with a significant depletion
rate of 49.05% ±0.166 (P < 0.001).
Metabolism assays with CYP6P9a: Similar to CYP6P9b
[4], recombinant CYP6P9a also metabolized both type I
and type II pyrethroids. A significant substrate depletion
of 20 μM type I permethrin and bifenthrin was observed;
65.68% ± 1.5 (P < 0.001) and 68.48% ± 2.65 (P < 0.0001) of
the substrate was deleted, respectively, by 90 minutes
post-incubation. Similar significant depletion levels were
also observed for the type II pyrethroids deltamethrin and
lambda-cyhalothrin, with substrate disappearance rates of
68.4% ± 0.83 (P < 0.001) and 75.41% ± 0.50 (P < 0.001), re-
spectively (Figure 4B). This enzyme also metabolized eto-
fenprox with a depletion rate of 46.04% ± 0.26 (P < 0.0014).
Turnover and kinetic profiles of CYP6M7, CYP6P9a and
CYP6P9b
A comparative analysis of the turnover of the three
enzymes during pyrethroid metabolism was performed.M7 with type I and type II pyrethroids. The turnover (time course)
C) is the Michaelis-Menten plot of CYP6P9a, CYP69b and CYP6M7 with
s the mean ± S.D. of three replicates.
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1.48 min−1 and 5.91 ± 1.64 min−1 for permethrin and delta-
methrin, respectively. CYP6P9b produced a turnover of
6.43 ± 1.40 min−1 and 7.041 ± 1.98 min−1 with permethrin
and deltamethrin, respectively. CYP6M7 followed the same
pattern, with turnovers of 5.71 ± 1.52 min−1 for permethrin
and 6.25 ± 1.67 min−1 for deltamethrin. These turnovers
are within similar ranges, indicating that these three dif-
ferent enzymes have similar in vitro metabolic profiles with
type I and type II pyrethroids.
Steady-state kinetic parameters for CYP6M7, CYP6P9a
and CYP6P9b are given in Table 2 and Figure 4C and D.
The KM values obtained were within normal ranges
associated with P450 metabolism (1–50 μM) in insects
[28,30,39,41] and in rats and mammals [42] but lower
than those observed for CYP6AA3 and CYP6P7 in An.
minimus with deltamethrin and permethrin [39].
For CYP6P9a, the apparent KM and rate constant (Kcat)
were within the same range for deltamethrin and per-
methrin, suggesting comparable affinity and metabolic
profiles for type I and type II pyrethroids. CYP6M7 ex-
hibited a lower KM (higher affinity) for permethrin than
deltamethrin, resulting in a higher catalytic efficiency
(Kcat/KM) with permethrin. CYP6P9b had the highest af-
finity (lower KM) and highest Kcat for both pyrethroids
compared with CYP6P9a and CYP6M7, which is reflected
in its higher catalytic efficiency for deltamethrin and per-
methrin. This enzyme therefore metabolizes pyrethroids,
particularly deltamethrin, with higher efficiency than both
CYP6P9a and CYP6M7 and other previously charac-
terized P450s [28,30,39,41]. Overall, for all three enzymes,
the reactions appeared to follow Michaelis-Menten kine-
tics, with Kcat values within the range recorded in the
literature for the activities of some insect P450s with
pyrethroids [28,30,39,41].
Genetic variability of candidate resistance genes in
relation to pyrethroid resistance
Polymorphism analysis of CYP6M7: Analysis of the
genetic variability of CYP6M7 full-length cDNA (1503 bp)
for five clones each from Mozambique, Malawi, Zambia
and the susceptible FANG strain revealed a high poly-
morphism of this gene, with an average of 45 polymorphic
sites observed for each sample and 22 amino acid changes
observed in total. In contrast to CYP6P9a and CYP6P9bTable 2 Kinetic parameters for permethrin and deltamethrin
Genes Catalytic constant (Kcat) (min−1) KM
Permethrin Deltamethrin Permethrin
CYP6P9a 8.11 ± 1.24 7.469 ± 1.25 18.77 ± 13.76
CYP6P9b 8.37 ± 1.13 7.90 ± 1.10 12.68 ± 10.08
CYP6M7 6.60 ± 0.24 7.035 ± 0.04 13.81 ± 7.075[4], no reduced variation in CYP6M7 was observed in the
resistant field samples compared to the susceptible strain
FANG. This is reflected by the absence of specific clades
based on resistance phenotype in the maximum likelihood
phylogenetic tree (Additional file 2: Figure S2), in contrast
to CYP6P9a and CYP6P9b [4].
Comparative analysis of CYP6M7 polymorphism in
resistant and susceptible mosquitoes: An analysis of
sequence polymorphisms in a 2,148 bp genomic fragment
spanning the full CYP6M7 gene (2 exons and 1 intron) and
a portion of the 5’ upstream region in five permethrin-
resistant and five susceptible mosquitoes from each of the
three countries revealed that CYP6M7 is highly poly-
morphic. This high diversity of CYP6M7 is reflected in
the elevated number of substitution sites (226) and high
haplotype diversity (51 haplotypes) detected across the
three countries (Additional file 1: Table S4). CYP6M7
polymorphism, based on the number of substitutions (S),
the nucleotide diversity (π), haplotype number and haplo-
type diversity (hd), is significantly higher across the three
countries than that of CYP6P9a and CYP6P9b (t-test,
P < 0.05) (Additional file 2: Figure S3A, S3B and S3C).
The higher polymorphism of CYP6M7 is further sup-
ported by a high number of singleton haplotypes in
CYP6M7 (38 of 43 haplotypes for the coding region), with
the most predominant haplotype in the three countries
found only at a frequency of 15.5% (Additional file 2:
Figure S3A), much lower than the equivalent frequencies
of 63% for CYP6P9a (Additional file 2: Figure S3B) and
62% for CYP6P9b (Additional file 2: Figure S3C). A similar
pattern was observed when the protein variants of these
three genes were compared (Additional file 2: Figure S4A,
S4B and S4C). In addition, the haplotype network of
CYP6M7 indicates that, in each of the three countries
(Figure 5A) and in the total sample, CYP6M7 haplotypes
are more diverse than those of CYP6P9a (Figure 5B) and
CYP6P9b (Figure 5C), as evidenced by an increase in the
number of mutational steps (>50) separating haplotypes.
In contrast to CYP6P9a and CYP6P9b, no apparent
correlation was observed between the genetic variability
of CYP6M7 and the resistance phenotype. Indeed, in the
maximum likelihood phylogenetic tree of the haplotypes
in each country, the haplotypes were not clustering ac-
cording to their resistance phenotype (Additional file 2:
Figure S5A), in contrast to the clustering observed for bothmetabolism by CYP6M7, CYP6P9a and CYP6P9b
(μM) Catalytic efficiency (Kcat/Km) (min−1 μM−1)
Deltamethrin Permethrin Deltamethrin
18.21 ± 8.904 0.432 ± 0.09 0.410 ± 0.141
9.9 ± 3.653 0.660 ± 0.112 0.798 ± 0.303
19.64 ± 10.69 0.478 ± 0.034 0.358 ± 0.004
Figure 5 Comparative analysis of haplotype diversity. The haplotype diversities of CYP6M7 (A) CYP6P9a (B) and CYP6P9b (C) were compared
using a 95% parsimony network based only on coding regions when combining the susceptible (S) and resistant (R) mosquitoes from each
country. For CYP6M7, networks are presented by country due to the large size of the combined network. These networks indicate the exceptional
diversity of CYP6M7 with high polymorphisms whereas CYP6P9a and CYP6P9b both exhibit reduced diversity, with the presence of a highly
predominant haplotype associated with resistance (directional selection). Haplotypes are represented as an oval or a rectangle scaled to reflect
their frequencies. The lines connecting haplotypes and each node represent a single mutation event. Gray shapes represent haplotypes unique in
susceptible mosquitoes; green shapes represent haplotypes predominantly found in resistant mosquitoes but also in some dead mosquitoes; red
shapes represent haplotypes unique to resistant mosquitoes. Some haplotypes with >20 mutation differences from others could not be linked to
the major network.
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(Additional file 2: Figure S5C). This lack of correlation be-
tween CYP6M7 polymorphism and permethrin resistance
is further supported by the similar levels of polymor-
phisms in both resistant and susceptible mosquitoes in the
3 countries, as measured by the number of polymorphic
sites or by haplotypic (hd) and genetic (π) diversities
(Additional file 1: Table S4 and Additional file 2:
Figure S6A), which also differs from the findings for
CYP6P9a (Additional file 2: Figure S6B) and CYP6P9b
(Additional file 2: Figure S6C). However, sliding window
analysis of the genetic diversity indicates a significant
difference in polymorphism levels between susceptible
and resistant samples for the 696 bp non-coding region(paired t-test, P < 0.01), with higher diversity among the
total susceptible sample across the three countries
compared to the resistant sample (Additional file 2:
Figure S6D). Sliding window analysis for both CYP6P9a
and CYP6P9b consistently revealed a higher diversity for
susceptible mosquitoes across the entire gene (Additional
file 2: Figure S6B and S6C).
Sliding window analysis of the genetic diversity of
CYP6M7 revealed that, as expected, this polymorphism
is higher in the 5’ upstream non-coding region than the
coding region for both the susceptible and resistant sam-
ples. Analysis of the coding region to detect polymor-
phism patterns associated with potential key functional
regions of the gene detected three regions that exhibited
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450 bp, 900–1100 bp and 1200–1350 bp (Additional file 2:
Figure S6D, Additional file 1: Table S4).
CYP6M7 selection test: Patterns of selection acting
on the coding region of CYP6M7 were analyzed using
the codon-based Z test of selection, which is based on
the dN/dS ratio, as implemented in MEGA 5.2. A
significant excess of synonymous substitutions per site
(dS) over non-synonymous substitutions (dN) was con-
sistently observed for both the susceptible and resistant
samples from all countries for the analysis averaging
over all sequence pairs within each group of samples
(Additional file 1: Table S5). The codon-based test per-
formed between sequence pairs also revealed that most
Z values (dS-dN) were positive, irrespective of the re-
sistance phenotype of the samples. A very high propor-
tion of Z values (dS-dN) (64 to 98.4%) were associated
with significant P values, supporting a significant excess of
synonymous substitutions per site over non-synonymous
substitutions (Additional file 1: Table S5).
Polymorphisms of CYP6P9a and CYP6P9b in the
Zambian sample: Analysis of the polymorphism patterns
of CYP6P9a and CYP6P9b in the Zambian sample re-
vealed the same reduction of genetic diversity (number of
substitutions, genetic diversity (π) and haplotype number)
in resistant mosquitoes that was previously observed in
the Malawian and Mozambican samples [4] (Additional
file 1: Table S6 and S7). However, both genes were more
variable in the Zambia sample than in the Mozambican
and Malawian samples with notably more mutational
steps between haplotypes. Indeed, only 1 haplotype of
CYP6P9a was more than 4 mutational steps from any
other in the Malawian and Mozambican samples, whereas
in the Zambia sample, all haplotypes were between 5 to
18 mutational steps apart (Additional file 2: Figure S7A,
S7B and S7C). In addition, the frequencies of the predo-
minant haplotypes of both genes were lower in Zambia.
This difference is more evident for the CYP6P9b, for
which the predominant haplotype (H1) found in the
Mozambican (84.5%; Additional file 2: Figure S7D) and
Malawian (95%; Additional file 2: Figure S7E) samples is
not present in the Zambian sample, which, by contrast,
featured two predominant haplotypes, ZB6 (40%) and ZB7
(35%) (Additional file 2: Figure S7F). These haplotypes
were separated by 1 and 2 mutations, respectively, from
haplotype H1 (Figure 5C). Furthermore, analysis of the
maximum likelihood tree of CYP6P9a and CYP6P9b hap-
lotypes detected a cluster of haplotypes only specific to
Zambia (Additional file 2: Figure S5B and S5C). The
differences observed in Zambia for both genes resulted in
a higher and significant genetic differentiation between
Zambia and the two other countries based on KST estimates
whereas no significant differentiation is observed between
Malawi and Mozambique (Additional file 1: Table S8). Incontrast, for CYP6M7 all populations were significantly
differentiated from each other. These patterns are con-
firmed by the phylogenetic trees based on genetic
distances (Additional file 2: Figure S5D, S5E and S5F).
Discussion
Insecticide resistance among Anopheles mosquitoes is
spreading throughout Africa, threatening the success of
malaria control methods. In this study, after characte-
rizing the insecticide resistance profile of an An. funestus
population from Zambia, we elucidated the molecular
and genetic basis of the resistance mechanisms driving
the expansion of the pyrethroid resistance front across
Southern Africa.
Expansion of the resistance front in An. funestus is likely
due to multiple independent selection events
The rapid spread of insecticide resistance from a single
localized origin to a large geographical region due to ex-
tensive gene flow between vector populations is of great
concern to control programs [2]. Determining whether
one or more resistance profiles are present can facilitate
the design and implementation of successful vector con-
trol strategies. The comparative analysis of the suscepti-
bility profile of the Zambian population with those of
the Mozambican and Malawian populations suggests
that the resistance observed in Southern Africa might
not have developed from a single origin and spread over
the region as previously suggested based on the simi-
larity between Mozambican and Malawian populations
[4,8]. Local selection factors probably play an important
role in the expansion of this resistance as highlighted by
the significant differences in the resistance profiles of
the Zambian population compared with the Malawian
and Mozambican populations. The DDT resistance ob-
served in the Zambian population contrasts with the full
susceptibility to this insecticide in the Mozambican
population and the very moderate resistance in the Ma-
lawian population, suggesting that local selection factors
in Zambia (from agriculture or from public health con-
trol interventions such as IRS) could be responsible for
this DDT resistance. The higher carbamate resistance of
the Zambian sample compared to the Malawian and
Mozambican samples further supports this observation.
In An. gambiae, local selection factors have played a
similarly important role in the development of resist-
ance, such as in the highly selected agricultural settings
in Burkina Faso [26,43] and in Benin [12]. However, the
rapid spread of the 1014 F kdr mutation in An. gambiae
[44] is a reminder that, with time, gene flow bet-
ween populations will also contribute to such resistance
expansion.
The variation in the susceptibility profile and resis-
tance genes observed in this study highlights the need to
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implementing control strategies because information
from a single country is insufficient to guide decision-
making in a neighboring country.
Expansion of pyrethroid resistance is driven by new
resistance genes: a challenge for the management of
metabolic resistance
This study has revealed that beside the previously con-
firmed P450s CYP6P9a and CYP6P9b resistance genes,
the CYP6M7 gene is likely also playing an important role
in the pyrethroid resistance in southern Africa as shown
by a consistent over-expression from microarray. The fact
that similar consistent over-expression for CYP6M7 was
observed from the qRT-PCR results using three different
primer pairs further validates the up-regulation of this
gene in relation to pyrethroid resistance. Interestingly,
probes from CYP6M3, the ortholog of CYP6M7 in An.
gambiae, were found to be significantly over-expressed in
the pyrethroid resistant laboratory An. funestus FUMOZ
strain compared to the laboratory susceptible FANG strain
during a microarray analysis using the An. gambiae “detox
chip” [45]. CYP6M7 was also previously mapped within
the rp2 pyrethroid resistance QTL in a crossing between
FUMOZ and FANG strains [21]. Altogether, the con-
sistent over-expression of CYP6M7 and the demonstration
that this gene can metabolize pyrethroids both in vitro
and in vivo, support the view that CYP6M7 is significantly
contributing to pyrethroid resistance in southern Africa.
The two to seven-fold reduced expression of both
CYP6P9a and CYP6P9b in Zambia from microarray in
contrast to Mozambique and Malawi, could even signal a
possible shift in underlying molecular basis of pyrethroid
resistance across the region with CYP6M7 possibly playing
a more important in such locations. However, it will be
useful in future studies to further validate this potential
shift in gene expression of the main resistance genes using
other methods such as RNAseq which contrary to micro-
array and qRT-PCR is not affected by the sequence poly-
morphism of targeted genes. The reasons for the potential
shift in the expression levels of the three genes remain un-
known but could be due to the nature of the selection that
gave rise to the resistance. This shift in gene expression
further highlights the genetic plasticity of natural popula-
tions of malaria vectors and their ability to adapt to vari-
ous selection pressures. Similar geographical variations in
expression levels between detoxification genes have been
observed in other mosquito vectors, such as An. gambiae
[38] and Aedes aegypti [46]. Furthermore, it is not un-
common for different P450 genes to be associated with a
same resistance profile such as the case for the CYP6A1
and CYP6D1 in the house fly Musca domestica, or for
CYP6A2, CYP6A8 and CYP6G1 in the fruit fly D. melano-
gaster [47]. Similarly in the red flour beetle Triboliumcastaneum several P450s including CYP6BQ8, CYP6BQ9
and CYP6BQ10 or CYP436B1 and CYP436B2, are shown
to confer deltamethrin resistance [40,48].
Functional characterization of the three cytochrome
P450 genes clearly demonstrated that they all confer to
An. funestus the ability to withstand both types I and II
pyrethroids. It will be a concern for control programs if
the three genes were equally highly up-regulated in a
single population, as this may significantly increase
the overall pyrethroid resistance level of such mosquito
populations.
However, kinetic analysis of the three recombinant en-
zymes suggests that CYP6P9b may metabolize pyrethroids
more efficiently than the other two enzymes. This result
will need to be further confirmed since kinetic profiles ob-
tained through in vitro experiments are unlikely to reflect
100% their in vivo patterns stemming from potential varia-
tions in the in vivo intrinsic clearance of the insecticide in
the mosquito. Variations in insecticide metabolism among
resistance genes are not uncommon and were previously
observed in D. melanogaster when seven P450 genes were
compared for their ability to confer resistance using trans-
genic expression [49]. However, more work is needed to
fully establish the metabolic efficiency of these enzymes
against all pyrethroids. Another area of investigation will
be to establish their patterns of cross-resistance to other
insecticide classes. Such P450 cross-resistance to different
insecticide classes was recently reported in An. gambiae
for the CYP6M2 gene [13] or for the CYP6G1 in D. mela-
nogaster which has been showed to metabolize a wide
range of insecticides [50]. Similarly, it will be interesting
to determine if the increased CYP6M7 expression in the
Zambian population also plays a role in the DDT re-
sistance or bendiocarb resistance observed in this country.
The change in the resistance profile observed in Zambia
was also reflected in the transcription profile of this
mosquito population with the over-expression of more
GSTs and carboxylesterases in this country. The low over-
expression of the GSTe2 gene, along with the absence
of the GSTe2 L119F mutation commonly associated with
DDT resistance in West Africa, suggest that the mecha-
nisms of DDT resistance in Zambia are different than
those observed in West and Central Africa [51]. The
seven-fold over-expression of the GSTD3 in Zambia than
in the DDT-susceptible populations of Mozambique and
Malawi could suggest that the up-regulation of this gene
could be associated with the DDT resistance in Zambia.
However, further work is needed to establish the exact
contribution of this gene and others with the resistance
observed against pyrethroids or DDT and bendiocarb in
this study. The contribution of several genes to metabolic
resistance to insecticides is a common trait in mosquitoes
and is also observed in other vectors such as An. gambiae,
in which the P450 gene, CYP6P3, combines with CYP6M2
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[12-14]. Similar phenomena have been observed in Ae.
aegypti, in which a set of CYP9 P450s play a major role in
resistance [52,53], and even in Drosophila, in which many
genes combine to protect against various spectrums of
insecticides [49]. The involvement of a multiplicity of
genes in metabolic resistance is a further challenge to the
ultimate aim of detecting resistance markers that could be
used to design suitable DNA-based diagnostic tools to
easily detect such resistance in the field.
Contrasting selection patterns shape the diversity of
CYP6M7 and the duplicated CYP6P9a and CYP6P9b
CYP6M7 is highly polymorphic, with 1 SNP every 15 bp
in the coding regions and 1 SNP every 9 bp when non-
coding regions are included. This level of polymorphism
far exceeds that previously reported for any P450 gene
in An. funestus [21,54] or An. gambiae [55]. Analysis of
the genetic diversity of CYP6M3, the CYP6M7 ortholog
in An. gambiae, revealed a far lower polymorphism level,
with only 1 SNP every 66 bp [55]. The high polymor-
phism of CYP6M7 is similar to that reported in An.
gambiae for the APL1 gene which is associated with
immune responses against Plasmodium falciparum [56].
It is unlikely that the high polymorphism of CYP6M7 is
associated with gene duplication, as good and clean se-
quencing results were consistently obtained from PCR
products of same size after amplification using primers
located in the 5’ and 3’UTR. In addition, a full sequen-
cing of the 113 kb of this genomic region spanning rp2
pyrethroid QTL did not detect any gene duplication of
CYP6M7 [21].
No particular CYP6M7 allele seems to be most asso-
ciated with pyrethroid resistance, in contrast to the iden-
tification of predominant resistance alleles of CYP6P9a
and CYP6P9b [4] suggesting that no selective sweep is
acting upon CYP6M7. This suggests that the major ge-
netic factor conferring resistance through CYP6M7
could be located in a trans regulatory region rather than
in the coding sequence, but this regulator remains to be
found. By contrast, the considerable differences observed
in the amino acid sequences of CYP6P9a and CYP6P9b
between resistant and susceptible mosquitoes suggests
that allelic variation at these two genes impact their
ability to confer pyrethroid resistance. Further work on
the regulation pathway of CYP6M7 will help to shed
more light into why it has not experienced the same
selective sweep as CYP6P9a and CYP6P9b.
The high polymorphism of CYP6M7 was nevertheless
associated with a significant predominance of syno-
nymous substitutions over non-synonymous substitu-
tions suggesting that CYP6M7 amino acid sequence was
under some selective constraints. However, the high
polymorphism level observed for CYP6M7 and the lackof predominant haplotype suggests that CYP6M7 is
overall probably evolving neutrally. This is in contrast to
both CYP6P9a and CYP6P9b were a signature of direc-
tional selection is observed with the selection of a
predominant haplotype and a reduced polymorphism in
resistance mosquitoes in all three countries. Beside a
possible trans-regulation of CYP6M7, the absence of a
directional selection on CYP6M7 could also stem from a
more generalist functional role of this gene, particularly
if it could protect the mosquito against a broad range of
xenobiotics or against plant toxins (allelochemicals) or
even if it were involved in functions other than detoxifi-
cation. This could explain why a single allele has not
been favored. By contrast, the directional selection act-
ing on both CYP6P9a and CYP6P9b with a selection of
favorable alleles could be due to a more specialist role of
these genes against mainly pyrethroid insecticides. Simi-
larly, structural differences associated with sequence
polymorphisms have been observed between the ge-
neralist cytochrome P450 CYP6B8 (which is able to
metabolize a variety of allelochemicals and insecticides)
in the polyphagous noctuid Helicoverpa zea and the spe-
cialist CYP6B1 in the black swallowtail butterfly Papilio
polyxenes, a specialist restricted to furanocoumarin-
containing plants [57]. Further evaluation of the sub-
strate spectrum metabolism of CYP6M7, CYP6P9a and
CYP6P9b is needed to confirm this hypothesis.
The higher genetic diversity of CYP6P9a and CYP6P9b
in the Zambian sample compared to the Malawian and
Mozambican samples correlates with the lower expres-
sion of both genes in the Zambian sample. This supports
the conclusion that both genes could be under less se-
lective pressure in Zambia. This variation in the diversity
of both genes in relation to their role in pyrethroid
resistance is similar to the differences in the genetic
variability of the glutathione S-transferase GSTe2 in An.
funestus with DDT resistance across Africa [51]. Very
low genetic variability is observed in high DDT resist-
ance regions, whereas higher variability is observed in
more susceptible regions [51]. A similar distribution of
variation in the CYP6G1 P450 gene has been associated
with DDT resistance in Drosophila simulans. This gene
has significantly lower diversity in DDT-resistant popu-
lations from California and higher polymorphism in
DDT-susceptible populations from Zimbabwe [58].
Conclusion
Taken together, the results from this study have helped
to shed more light into the molecular complexities of
the resistance mechanisms underlying pyrethroid resis-
tance in southern African populations of An. funestus.
Indeed, this study has revealed that beside the previously
known resistance genes CYP6P9a and CYP6P9b, the
CYP6M7 P450 gene is also playing a key role in the
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role may even become more important in the northern
range of the resistance front such as in Zambia. There-
fore, despite the similarities observed, the underlying
molecular basis of pyrethroid resistance is probably not
uniform across its distribution range in Southern Africa.
The northern range in Zambia exhibits significant dif-
ferences from Malawi and Mozambique in term of the
profile and molecular basis of resistance. It is therefore
likely that beyond Mozambique and Malawi, pyrethroid
resistance in southern Africa has multiple origins under
different evolutionary forces, which may necessitate the
design of different resistance management strategies to
mitigate the impact of this resistance.
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